KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inovio Pharmaceuticals (INO) Interest Coverage Ratio (2019 - 2024)

Inovio Pharmaceuticals (INO) has disclosed Interest Coverage Ratio for 6 consecutive years, with 177.05 as the latest value for Q1 2024.

  • Quarterly Interest Coverage Ratio fell 26.28% to 177.05 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was 632.05 through Dec 2024, down 436.93% year-over-year, with the annual reading at 632.05 for FY2024, 436.93% down from the prior year.
  • Interest Coverage Ratio hit 177.05 in Q1 2024 for Inovio Pharmaceuticals, down from 97.03 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 9.0 in Q1 2020 to a low of 332.19 in Q2 2022.
  • Historically, Interest Coverage Ratio has averaged 128.94 across 5 years, with a median of 118.16 in 2023.
  • Biggest five-year swings in Interest Coverage Ratio: surged 79.3% in 2020 and later plummeted 1429.38% in 2021.
  • Year by year, Interest Coverage Ratio stood at 27.47 in 2020, then plummeted by 699.62% to 219.67 in 2021, then grew by 18.76% to 178.46 in 2022, then soared by 45.63% to 97.03 in 2023, then tumbled by 82.47% to 177.05 in 2024.
  • Business Quant data shows Interest Coverage Ratio for INO at 177.05 in Q1 2024, 97.03 in Q4 2023, and 113.41 in Q3 2023.